A) Treatment schedule representing one cycle of the various immunotherapeutic injections.
B) Average values of tumor growth as a function of time post-implantation for the different treatment groups.
|
| Figure 1: A vaccine was prepared from allogeneic and syngeneic antigens
and administered in a fractionated regimen together with BCG and IL-2
to determine the effects on CNS-1 glioma growth. A) Treatment schedule representing one cycle of the various immunotherapeutic injections. B) Average values of tumor growth as a function of time post-implantation for the different treatment groups. |
